Please login to the form below

Not currently logged in
Email:
Password:

Adderall

This page shows the latest Adderall news and features for those working in and with pharma, biotech and healthcare.

Shire offloads oncology unit to Servier for $2.4bn

Shire offloads oncology unit to Servier for $2.4bn

The neuroscience arm includes Shire’s attention-deficit hyperactivity drugs such as Adderall XR (mixed amphetamine salts) and brought in $2.66bn in sales last year.

Latest news

More from news
Approximately 3 fully matching, plus 88 partially matching documents found.

Latest Intelligence

  • Challenging perceptions Challenging perceptions

    Meanwhile, the US also has the amphetamine-based class - Shire's historic territory with Adderall and its flagship product Vyvanse. “

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Shire elects new chair Shire elects new chair

    During that time Shire has grown substantially, although has struggled in recent years with generic competition for big-selling attention deficit-hyperactivity disorder (ADHD) drug Adderall XR and plans to downsize

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics